Novel studies suggest that Retatrutide , a combined agonist targeting incretin and gastric inhibitory peptide pathways , appears to be the breakthrough in weight management . Early clinical trials https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide